• English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
July 12th - According to the Ministry of Education, this year marks the 20th anniversary of the student loan program based on the students place of origin. Over the past two decades, my countrys student loan program has cumulatively issued 620.7 billion yuan in loans, benefiting 68.21 million students.July 12th - According to Middle East Eye, the United States is collaborating with Iraq and Syria on a plan to upgrade an aging oil pipeline connecting the northern Iraqi city of Kirkuk to Baniyas on Syrias Mediterranean coast, enabling Iraq to bypass the Strait of Hormuz when exporting crude oil. The report, citing Iraqi and other regional officials, stated that an agreement to restore the approximately 800-kilometer-long pipeline is expected to be announced next week during Iraqi Prime Minister Ali Zaidis meeting with Trump at the White House. The pipeline, which has been out of service for decades, is currently severely damaged. The report quoted a senior official as saying that the pipeline will likely require complete reconstruction, a project expected to take two to three years. Several American companies have already been recruited to participate in the project.July 11 - Irans Permanent Representative to the United Nations, Illavani, warned on the 11th that if the United States continues to violate its obligations, Iran will no longer abide by the memorandum of understanding signed with the United States.According to Axios, a regional source said that parties are discussing the possibility of issuing a potential statement on the full opening and free passage of the "middle channel" (located in international waters) in the Strait of Hormuz.According to RIA Novosti, the Russian Ministry of Defense stated that Ukrainian President Zelenskyy has deployed almost all available Western missile defense systems to Kyiv.

Pfizer seeks U.S. approval for a reformulated Omicron vaccination booster

Aria Thomas

Aug 23, 2022 10:55

5.png


Pfizer Inc (NYSE:PFE) and its German partner BioNTech stated on Monday that they had submitted an application for U.S. approval of a COVID-19 vaccine booster modified to target the Omicron form and that doses would be available for distribution immediately following regulatory clearance.


The request to the Food and Drug Administration was for a bivalent vaccine containing both the widespread BA.4/BA.5 variants and the original coronavirus strain. It is intended for persons older than 12 years.


Pfizer indicated that it was set to fulfill a $3.2 billion contract with the United States government for 105 million doses, including Omicron-tailored injections, in September.


Albert Bourla, the chief executive officer of Pfizer, said in a statement, "We are prepared to immediately begin distribution of the bivalent Omicron BA.4/BA.5 boosters if approved."


Countries, including the United Kingdom, the United States, and members of the European Union, have prepared fall vaccination campaigns to protect against future outbreaks. The United Kingdom was the first nation to approve a bivalent immunization developed by Moderna last week (NASDAQ:MRNA).


Bourla announced on Twitter that Pfizer plans to finalize its submission to the European Medicines Agency in the next few days (NYSE:TWTR).


Similar to how annual changes to influenza vaccinations are handled, the FDA requested in June that COVID-19 vaccine producers modify injections to target the two sub variants and noted that it would not require new human testing studies for approval.


According to mid- to late-stage studies, Pfizer's older BA.1-tailored vaccine demonstrated a superior immune response against the subvariant.


This month, it is anticipated that a study of the BA.4/BA.5 vaccine in adults aged 12 and older would commence.